Alterations of p16/CDKN2, p53 and ras genes in oral squamous cell carcinomas and premalignant lesions
- 1 May 1996
- journal article
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 25 (5) , 232-238
- https://doi.org/10.1111/j.1600-0714.1996.tb01377.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Germline p16 mutations in familial melanomaNature Genetics, 1994
- Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancersNature, 1994
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cellsCell, 1992
- p53, guardian of the genomeNature, 1992
- Assessment of p53 protein expression in normal, benign, and malignant oral mucosaThe Journal of Pathology, 1992
- High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in IndiaBritish Journal of Cancer, 1991
- Low incidence of ras oncogene activation in human squamous cell carcinomasBritish Journal of Cancer, 1990
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- Premalignant changes in normal appearing epithelium in patients with squamous cell carcinoma of the upper aerodigestive tractThe American Journal of Surgery, 1982